Quantifying your body: a how-to guide from a systems biology perspective (Q28272991)

https://api.crossref.org/works/10.1002%2FBIOT.201100495

A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Sleep quality versus sleep quantity: relationships between sleep and measures of health, well-being and sleepiness in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Neuroendocrinology and pathophysiology of the stress system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

The neurobiology of stress and gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Principles and clinical implications of the brain-gut-enteric microbiota axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Systems biology and new technologies enable predictive and preventative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Revolutionizing medicine in the 21st century through systems approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Estimates of optimal vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Coronary artery calcium score and risk classification for coronary heart disease prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Omega-3 fatty acids in inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

The importance of the ratio of omega-6/omega-3 essential fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Review of fecal biomarkers in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Interactions between the host innate immune system and microbes in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

The gut microbiota. Introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

A framework for human microbiome research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

The microbial contribution to human faecal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Long-term ecological impacts of antibiotic administration on the human intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Metabolomics reveals metabolic biomarkers of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Personal omics profiling reveals dynamic molecular and medical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Gut microbiome-host interactions in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Gut microbiota in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Unravelling the effects of the environment and host genotype on the gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

Preparing for Precision Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100495

21 January 2018

Identifiers

DOI

10.1002/BIOT.201100495

1 reference

Consolidated OpenCitations Corpus – April 2017

1234171

1234171

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference